Several genetic variants of the TPMT gene have been identified, with TPMT*1 representing the wild-type allele. The most common variants associated with decreased activity include TPMT*2, TPMT*3A, and TPMT*3C. These variants result in reduced enzyme function and increased risk of drug toxicity. Understanding these variants is crucial for tailoring thiopurine therapy.
